Local ozone injection compared to local glucocorticoid injection in carpal tunnel syndrome: A randomized controlled trial

局部臭氧注射与局部糖皮质激素注射治疗腕管综合征的比较:一项随机对照试验

阅读:1

Abstract

OBJECTIVES: This study aimed to compare the effectiveness of local ozone (O(3)) injection versus corticosteroid injection in the treatment of mild to moderate carpal tunnel syndrome (CTS). PATIENTS AND METHODS: This double-blind randomized controlled trial was performed on 42 patients (9 males, 33 females; mean age: 46.7±2.1 years; range, 18 to 70 years) with mild to moderate CTS between May 2021 and June 2021. The corticosteroid group (n=21) was injected with 40 mg triamcinolone, and in the O(3) group B (n=21), 4 mL of a 10 mcg/mL oxygen (O(2))-O(3) mixture was injected. Symptom severity and functional impairments were assessed using a Visual Analog Scale and Boston Carpal Tunnel Questionnaire. Electrodiagnostic and ultrasonographic parameters were obtained at baseline and eight weeks after the procedure. RESULTS: The O(2)-O(3) solution improved pain and Boston Carpal Tunnel Questionnaire score after eight weeks (p<0.001); however, the change was nonsignificant compared to the corticosteroid group (p>0.05). Sensory nerve and compound muscle action potential latencies were not significantly changed eight weeks after O(2)-O(3) injection (p>0.05), while both were significantly decreased in the steroid injection group (p<0.001). Volar bulging and median nerve cross-section surface area were not improved after O(2)-O(3) injection, while the improvement was significant in the corticosteroid arm (p=0.02). CONCLUSION: Symptoms in patients with mild to moderate CTS may be alleviated by local O(2)-O(3) injection; however, electrodiagnostic and ultrasonographic indices may be unchanged. Corticosteroid local injection may alleviate patient symptoms along with electrodiagnostic and ultrasonographic parameters.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。